병원 및 요양시설용 프로바이오틱스 시장 규모는 향후 몇 년 동안 연평균 11.44% 성장하여 2029년에는 26억 1,000만 달러에 달할 것으로 예측됩니다. 향후 프로바이오틱스 사용 확대, 소화기 건강 솔루션에 대한 수요 증가, 프로바이오틱스에 대한 인식 개선, 병원 내 감염(HAI) 예방에 대한 강조, 프로바이오틱스 기반 의료용 영양에 대한 투자 확대 등이 예측 기간 동안 시장 성장을 견인할 것으로 보입니다. 예측 기간 동안 주요 동향으로는 프로바이오틱스 제제의 혁신, 특정 의료 환경에 맞는 전달 방법 강화, 감염 예방을 위한 새로운 프로바이오틱스, 고령자 및 면역 결핍 환자를 위한 특수 프로바이오틱스 개발, 디지털 기술 통합 등이 있습니다.
위장 질환의 유병률 증가는 병원 및 요양시설용 프로바이오틱스 시장의 성장을 견인할 것으로 예측됩니다. 이러한 질환에는 과민성 대장 증후군(IBS), 염증성 장질환(IBD), 위식도 역류질환(GERD), 변비 등 소화기 계통에 영향을 미치는 다양한 질환이 포함됩니다. 이러한 질환 증가는 건강에 해로운 식습관, 가공식품 섭취 증가, 좌식 생활, 스트레스 증가 등의 요인과 관련이 있습니다. 병원 및 요양시설에서 사용되는 프로바이오틱스는 장내 유익균의 균형을 회복하고 소화기 건강을 개선하며 설사, 변비, 복부 팽만감 등의 증상을 완화하여 위장 장애를 관리하는 데 도움이 될 수 있습니다. 예를 들어, 2023년 12월 영국의 비영리단체인 IBD 레지스트리(IBD Registry)는 2023년까지 염증성 장질환(IBD) 환자 수가 5,300명을 돌파하여 2022년에 비해 3,000명 이상 증가할 것이라고 보고했습니다. 그 결과, 소화기 질환의 유병률 증가는 병원 및 요양시설용 프로바이오틱스 시장의 성장에 기여하고 있습니다.
병원 및 요양시설용 프로바이오틱스 시장에서 활동하는 기업들은 장 건강을 개선하고 회복을 촉진하며 항생제 부작용을 최소화하는 프로바이오틱스 솔루션과 같은 혁신적인 제품을 만드는 데 주력하고 있습니다. 프로바이오틱스 솔루션은 살아있는 미생물을 함유하고 있으며, 충분한 양을 섭취하면 소화기관 내 유익균의 균형을 개선하여 건강상의 이점을 제공합니다. 예를 들어, 2024년 10월 스웨덴의 생명공학 기업 프로비 AB(Probi AB)는 헬스케어 환경을 위한 'Metabolic Health by Probi'를 출시했습니다. 이 임상적으로 입증된 프로바이오틱 솔루션은 락토바실러스 파라카세이 8700:2(L. Paracasei 8700:2)와 락토바실러스 플란타럼 299v(LP299V) 두 가지 독자적인 균주를 결합하여 대사 건강, 심혈관 건강, 체중 관리, 혈압 조절, 체중 조절을 촉진합니다. 혈압 조절을 촉진합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나바이러스 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
- 세계 병원 및 요양시설용 프로바이오틱스 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
- 최종 이용 산업 분석
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 성장률 분석
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 실적 : 규모와 성장, 2019-2024
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 예측 : 규모와 성장, 2024-2029, 2034F
- 세계 병원 및 요양시설용 프로바이오틱스 전체 시장(TAM)
제6장 시장 세분화
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 적응증별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 항생제 관련 설사
- 과민성 장증후군
- 클로스트리듐 디피실 감염증
- 염증성 장질환
- 일반 장 건강
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 처방 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 캡슐
- 분말
- 액체
- 소프트 츄
- 프로바이오틱스 요거트
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 환자 그룹별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 유아
- 성인
- 노인
- 면역 결핍 환자
- 위장 질환 환자
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 병원
- 요양시설
- 약국
- 온라인 소매
- 의료시설
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 장 건강
- 면역
- 웰니스
- 기타 용도
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 항생제 관련 설사증(AAD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- AAD 예방
- AAD 치료
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 과민성 장증후군(IBS)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 설사를 수반하는 과민성 장증후군(IBS-D)
- 변비를 수반하는 과민성 장증후군(IBS-C)
- 혼합성 IBS(IBS-M)
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 클로스트리듐 디피실 감염증(CDI)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- CDI 재발 예방
- CDI 치료
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 염증성 장질환(IBD)별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 크론병
- 궤양성 대장염
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 유형별 장 건강별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 면역 시스템 지원
- 소화기계 건강
- 장내 미생물총 회복
제7장 지역별/국가별 분석
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
- 세계의 병원 및 요양시설용 프로바이오틱스 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
- 병원 및 요양시설용 프로바이오틱스 시장 : 경쟁 구도
- 병원 및 요양시설용 프로바이오틱스 시장 : 기업 개요
- Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
- BASF SE Overview, Products and Services, Strategy and Financial Analysis
- Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
- Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- Lactalis Group Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업 및 혁신 기업
- Danone S.A.
- General Mills Inc.
- Arla Foods Group
- DuPont de Nemours Inc.
- Kerry Group plc
- Koninklijke DSM N.V.
- Glanbia PLC
- Yakult Honsha Co. Ltd.
- Chr. Hansen Holding A/S
- Lallemand Inc.
- BioGaia AB
- Klaire Labs
- SymbioPharm GmbH
- Synlogic Inc.
- Vitakem Nutraceuticals
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
- 병원 및 요양시설용 프로바이오틱스 시장(2029년) : 새로운 기회를 제공하는 국가
- 병원 및 요양시설용 프로바이오틱스 시장(2029년) : 새로운 기회를 제공하는 부문
- 병원 및 요양시설용 프로바이오틱스 시장(2029년) : 성장 전략
제36장 부록
LSH
Hospital and nursing home probiotics are dietary supplements containing live microorganisms, typically beneficial bacteria, that provide health benefits when consumed in adequate amounts. These probiotics are particularly valuable for supporting digestive health, boosting immune function, and improving general wellbeing, especially for vulnerable populations such as the elderly and patients with weakened immune systems.
The primary indications for using probiotics in hospital and nursing home settings include conditions such as antibiotic-associated diarrhea, irritable bowel syndrome (IBS), Clostridium difficile infection, inflammatory bowel disease (IBD), and general gut health maintenance. Antibiotic-associated diarrhea, in particular, is a common issue resulting from the disruption of gut microbiota due to antibiotics, and probiotics are often used to restore balance and alleviate symptoms. Probiotics come in various formulations, including capsules, powders, liquids, soft chews, and probiotic yogurt, allowing for flexible administration tailored to the needs of different patient groups, such as infants, adults, the elderly, immunocompromised patients, and those with gastrointestinal disorders. These products are distributed through a variety of channels, including hospitals, nursing homes, pharmacies, online retail, and healthcare facilities, and they are used primarily in areas related to gut health, immunity, and overall wellness.
The hospital and nursing home probiotics market research report is one of a series of new reports from The Business Research Company that provides hospital and nursing home probiotics market statistics, including the hospital and nursing home probiotics industry global market size, regional shares, competitors with the hospital and nursing home probiotics market share, detailed hospital and nursing home probiotics market segments, market trends, and opportunities, and any further data you may need to thrive in the hospital and nursing home probiotics industry. This hospital and nursing home probiotics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The hospital and nursing home probiotics market size has grown rapidly in recent years. It will grow from $1.51 billion in 2024 to $1.69 billion in 2025 at a compound annual growth rate (CAGR) of 11.81%. The growth observed in the historical period can be credited to the increasing awareness surrounding gut health, a higher prevalence of gastrointestinal disorders, the rising use of probiotics in healthcare, and the growing body of evidence highlighting the health benefits of probiotics.
The hospital and nursing home probiotics market size is expected to see rapid growth in the next few years. It will grow to $2.61 billion in 2029 at a compound annual growth rate (CAGR) of 11.44%. Looking ahead, the growth in the forecast period is expected to be driven by the expanding use of probiotics, a higher demand for digestive health solutions, increased awareness of probiotics, a stronger emphasis on preventing hospital-acquired infections (HAIs), and growing investments in probiotic-based medical nutrition. Key trends in the forecast period include innovations in probiotic formulations, enhancements in delivery methods tailored for specific healthcare environments, new probiotics aimed at infection prevention, the development of specialized probiotics for the elderly and immunocompromised patients, and the integration of digital technologies.
The growing prevalence of gastrointestinal disorders is expected to drive the expansion of the hospital and nursing home probiotics market. These disorders encompass various conditions affecting the digestive system, such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and constipation. The rise in these conditions is linked to factors such as unhealthy eating habits, a higher intake of processed foods, sedentary lifestyles, and elevated stress levels. Probiotics used in hospitals and nursing homes help manage gastrointestinal disorders by restoring the balance of beneficial bacteria in the gut, improving digestive health, and alleviating symptoms such as diarrhea, constipation, and bloating. For example, in December 2023, the IBD Registry, a UK-based non-profit organization, reported that the number of people with inflammatory bowel disease (IBD) surpassed 5,300 by 2023, an increase of more than 3,000 individuals compared to 2022. As a result, the rising incidence of gastrointestinal disorders is contributing to the growth of the hospital and nursing home probiotics market.
Companies operating in the hospital and nursing home probiotics market are focusing on creating innovative products such as probiotic solutions to enhance gut health, accelerate recovery, and minimize side effects associated with antibiotics. Probiotic solutions contain live microorganisms that offer health benefits when consumed in sufficient quantities, typically by improving the balance of good bacteria in the digestive system. For example, in October 2024, Probi AB, a biotechnology company from Sweden, launched "Metabolic Health by Probi" for healthcare environments. This clinically supported probiotic solution combines two proprietary strains, Lactiplantibacillus plantarum 299v (LP299V) and Lacticaseibacillus paracasei 8700:2 (L. Paracasei 8700:2), to promote metabolic health, cardiovascular well-being, weight management, and blood pressure regulation.
In June 2023, Clasado Limited, a UK-based biotechnology firm, collaborated with Probi AB to further develop synbiotic products targeting gut health. The partnership aims to combine their expertise to advance the development and commercialization of scientifically supported synbiotics, which offer specific health benefits for consumers. Probi AB, based in Sweden, specializes in the development and commercialization of probiotic products backed by scientific research, preclinical studies, and clinical trials.
Major players in the hospital and nursing home probiotics market are Nestle Health Science, BASF SE, Procter & Gamble Company, Abbott Laboratories, Lactalis Group, Danone S.A., General Mills Inc., Arla Foods, DuPont de Nemours Inc., Kerry Group plc, Koninklijke DSM N.V., Glanbia PLC, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Klaire Labs, SymbioPharm GmbH, Synlogic Inc., Vitakem Nutraceuticals.
North America was the largest region in the hospital and nursing home probiotics market in 2024. The regions covered in hospital and nursing home probiotics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the hospital and nursing home probiotics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The hospital and nursing home probiotics market includes revenues earned by entities by sales of probiotic-infused wound care products, probiotic-infused foods, and medical-grade probiotics and related services such as probiotic therapy and consultation, infection control and prevention, probiotic supplementation programs, and probiotic administration monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Hospital And Nursing Home Probiotics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on hospital and nursing home probiotics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for hospital and nursing home probiotics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hospital and nursing home probiotics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
- Markets Covered:1) By Indication: Antibiotic-Associated Diarrhea; Irritable Bowel Syndrome; Clostridium difficile Infection; Inflammatory Bowel Disease; General Gut Health
- 2) By Formulation Type: Capsules; Powder; Liquid; Soft Chew; Probiotic Yogurt
- 3) By Patient Group: Infants; Adults; Elderly; Immunocompromised Patients; Patients With Gastrointestinal Disorders
- 4) By Distribution Channel: Hospitals; Nursing Homes; Pharmacies; Online Retail; Healthcare Facilities
- 5) By Application: Gut Health; Immunity; Wellness; Other Applications
- Subsegments:
- 1) By Antibiotic-Associated Diarrhea (AAD): Prevention of AAD; Treatment of AAD
- 2) By Irritable Bowel Syndrome (IBS): IBS With Diarrhea (IBS-D); IBS With Constipation (IBS-C); Mixed IBS (IBS-M)
- 3) By Clostridium Difficile Infection (CDI): Prevention of CDI Recurrence; Treatment Of CDI
- 4) By Inflammatory Bowel Disease (IBD): Crohn's Disease; Ulcerative Colitis
- 5) By General Gut Health: Immune System Support; Digestive Health; Gut Microbiome Restoration
- Companies Mentioned: Nestle Health Science; BASF SE; Procter & Gamble Company; Abbott Laboratories; Lactalis Group
- Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
- Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
- Time series: Five years historic and ten years forecast.
- Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
- Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
- Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Hospital And Nursing Home Probiotics Market Characteristics
3. Hospital And Nursing Home Probiotics Market Trends And Strategies
4. Hospital And Nursing Home Probiotics Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Hospital And Nursing Home Probiotics Growth Analysis And Strategic Analysis Framework
- 5.1. Global Hospital And Nursing Home Probiotics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Hospital And Nursing Home Probiotics Market Growth Rate Analysis
- 5.4. Global Hospital And Nursing Home Probiotics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Hospital And Nursing Home Probiotics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Hospital And Nursing Home Probiotics Total Addressable Market (TAM)
6. Hospital And Nursing Home Probiotics Market Segmentation
- 6.1. Global Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Antibiotic-Associated Diarrhea
- Irritable Bowel Syndrome
- Clostridium difficile Infection
- Inflammatory Bowel Disease
- General Gut Health
- 6.2. Global Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Capsules
- Powder
- Liquid
- Soft Chew
- Probiotic Yogurt
- 6.3. Global Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Infants
- Adults
- Elderly
- Immunocompromised Patients
- Patients With Gastrointestinal Disorders
- 6.4. Global Hospital And Nursing Home Probiotics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals
- Nursing Homes
- Pharmacies
- Online Retail
- Healthcare Facilities
- 6.5. Global Hospital And Nursing Home Probiotics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Gut Health
- Immunity
- Wellness
- Other Applications
- 6.6. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Antibiotic-Associated Diarrhea (AAD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prevention of AAD
- Treatment of AAD
- 6.7. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Irritable Bowel Syndrome (IBS), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- IBS With Diarrhea (IBS-D)
- IBS With Constipation (IBS-C)
- Mixed IBS (IBS-M)
- 6.8. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Clostridium Difficile Infection (CDI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Prevention of CDI Recurrence
- Treatment Of CDI
- 6.9. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of Inflammatory Bowel Disease (IBD), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Crohn's Disease
- Ulcerative Colitis
- 6.10. Global Hospital And Nursing Home Probiotics Market, Sub-Segmentation Of General Gut Health, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immune System Support
- Digestive Health
- Gut Microbiome Restoration
7. Hospital And Nursing Home Probiotics Market Regional And Country Analysis
- 7.1. Global Hospital And Nursing Home Probiotics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Hospital And Nursing Home Probiotics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Hospital And Nursing Home Probiotics Market
- 8.1. Asia-Pacific Hospital And Nursing Home Probiotics Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Hospital And Nursing Home Probiotics Market
- 9.1. China Hospital And Nursing Home Probiotics Market Overview
- 9.2. China Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Hospital And Nursing Home Probiotics Market
- 10.1. India Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Hospital And Nursing Home Probiotics Market
- 11.1. Japan Hospital And Nursing Home Probiotics Market Overview
- 11.2. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Hospital And Nursing Home Probiotics Market
- 12.1. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Hospital And Nursing Home Probiotics Market
- 13.1. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Hospital And Nursing Home Probiotics Market
- 14.1. South Korea Hospital And Nursing Home Probiotics Market Overview
- 14.2. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Hospital And Nursing Home Probiotics Market
- 15.1. Western Europe Hospital And Nursing Home Probiotics Market Overview
- 15.2. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Hospital And Nursing Home Probiotics Market
- 16.1. UK Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Hospital And Nursing Home Probiotics Market
- 17.1. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Hospital And Nursing Home Probiotics Market
- 18.1. France Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Hospital And Nursing Home Probiotics Market
- 19.1. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Hospital And Nursing Home Probiotics Market
- 20.1. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Hospital And Nursing Home Probiotics Market
- 21.1. Eastern Europe Hospital And Nursing Home Probiotics Market Overview
- 21.2. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Hospital And Nursing Home Probiotics Market
- 22.1. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Hospital And Nursing Home Probiotics Market
- 23.1. North America Hospital And Nursing Home Probiotics Market Overview
- 23.2. North America Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Hospital And Nursing Home Probiotics Market
- 24.1. USA Hospital And Nursing Home Probiotics Market Overview
- 24.2. USA Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Hospital And Nursing Home Probiotics Market
- 25.1. Canada Hospital And Nursing Home Probiotics Market Overview
- 25.2. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Hospital And Nursing Home Probiotics Market
- 26.1. South America Hospital And Nursing Home Probiotics Market Overview
- 26.2. South America Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Hospital And Nursing Home Probiotics Market
- 27.1. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Hospital And Nursing Home Probiotics Market
- 28.1. Middle East Hospital And Nursing Home Probiotics Market Overview
- 28.2. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Hospital And Nursing Home Probiotics Market
- 29.1. Africa Hospital And Nursing Home Probiotics Market Overview
- 29.2. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Hospital And Nursing Home Probiotics Market, Segmentation By Patient Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Hospital And Nursing Home Probiotics Market Competitive Landscape And Company Profiles
- 30.1. Hospital And Nursing Home Probiotics Market Competitive Landscape
- 30.2. Hospital And Nursing Home Probiotics Market Company Profiles
- 30.2.1. Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. BASF SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Procter & Gamble Company Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Lactalis Group Overview, Products and Services, Strategy and Financial Analysis
31. Hospital And Nursing Home Probiotics Market Other Major And Innovative Companies
- 31.1. Danone S.A.
- 31.2. General Mills Inc.
- 31.3. Arla Foods Group
- 31.4. DuPont de Nemours Inc.
- 31.5. Kerry Group plc
- 31.6. Koninklijke DSM N.V.
- 31.7. Glanbia PLC
- 31.8. Yakult Honsha Co. Ltd.
- 31.9. Chr. Hansen Holding A/S
- 31.10. Lallemand Inc.
- 31.11. BioGaia AB
- 31.12. Klaire Labs
- 31.13. SymbioPharm GmbH
- 31.14. Synlogic Inc.
- 31.15. Vitakem Nutraceuticals
32. Global Hospital And Nursing Home Probiotics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Hospital And Nursing Home Probiotics Market
34. Recent Developments In The Hospital And Nursing Home Probiotics Market
35. Hospital And Nursing Home Probiotics Market High Potential Countries, Segments and Strategies
- 35.1 Hospital And Nursing Home Probiotics Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Hospital And Nursing Home Probiotics Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Hospital And Nursing Home Probiotics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
